Business Description
RVL Pharmaceuticals PLC
NAICS : 325412
SIC : 2833
ISIN : IE00BF2HDL56
Description
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.19 | |||||
| Debt-to-Equity | 3.56 | |||||
| Debt-to-EBITDA | -1.02 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -12.29 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.6 | |||||
| 3-Year EBITDA Growth Rate | 49.8 | |||||
| 3-Year EPS without NRI Growth Rate | -22.1 | |||||
| 3-Year Book Growth Rate | -38.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.98 | |||||
| 9-Day RSI | 24.69 | |||||
| 14-Day RSI | 30.4 | |||||
| 6-1 Month Momentum % | -83 | |||||
| 12-1 Month Momentum % | -93.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.38 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 27.4 | |||||
| Days Sales Outstanding | 8.22 | |||||
| Days Payable | 156.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -24.1 | |||||
| Shareholder Yield % | -347679.09 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.73 | |||||
| Operating Margin % | -118.02 | |||||
| Net Margin % | -184.91 | |||||
| FCF Margin % | -128.07 | |||||
| ROE % | -145.57 | |||||
| ROA % | -56.4 | |||||
| ROIC % | -46.73 | |||||
| ROC (Joel Greenblatt) % | -2470.53 | |||||
| ROCE % | -62.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.68 | |||||
| EV-to-Forward-EBIT | -2.2 | |||||
| EV-to-EBITDA | -0.69 | |||||
| EV-to-Revenue | 1.06 | |||||
| EV-to-Forward-Revenue | 1.06 | |||||
| EV-to-FCF | -0.82 | |||||
| Earnings Yield (Greenblatt) % | -147.06 | |||||
| FCF Yield % | -431681.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RVL Pharmaceuticals PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 35.251 | ||
| EPS (TTM) (€) | -0.666 | ||
| Beta | 0 | ||
| Volatility % | 142.3 | ||
| 14-Day RSI | 30.4 | ||
| 14-Day ATR (€) | 0.013081 | ||
| 20-Day SMA (€) | 0.054875 | ||
| 12-1 Month Momentum % | -93.31 | ||
| 52-Week Range (€) | 0.003 - 1.75 | ||
| Shares Outstanding (Mil) | 111.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RVL Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RVL Pharmaceuticals PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
RVL Pharmaceuticals PLC Frequently Asked Questions
What is RVL Pharmaceuticals PLC(FRA:O1P)'s stock price today?
The current price of FRA:O1P is €0.00. The 52 week high of FRA:O1P is €1.75 and 52 week low is €0.00.
When is next earnings date of RVL Pharmaceuticals PLC(FRA:O1P)?
The next earnings date of RVL Pharmaceuticals PLC(FRA:O1P) is 2024-04-18 Est..
Does RVL Pharmaceuticals PLC(FRA:O1P) pay dividends? If so, how much?
RVL Pharmaceuticals PLC(FRA:O1P) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers